Connection
Martin Krsak to Aged
This is a "connection" page, showing publications Martin Krsak has written about Aged.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.075 |
|
|
|
-
Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections. J Antimicrob Chemother. 2019 08 01; 74(8):2405-2416.
Score: 0.047
-
Texidor WM, Miller MA, Molina KC, Krsak M, Calvert B, Hart C, Storer M, Fish DN. Oritavancin as sequential therapy for Gram-positive bloodstream infections. BMC Infect Dis. 2024 Jan 24; 24(1):127.
Score: 0.016
-
Solis J, Franco-Paredes C, Henao-Mart?nez AF, Krsak M, Zimmer SM. Structural Vulnerability in the U.S. Revealed in Three Waves of COVID-19. Am J Trop Med Hyg. 2020 07; 103(1):25-27.
Score: 0.012